Keryx Biopharmaceuticals is classified as operating in the Legal Services industry, NAICS Code 5411.
Keryx Biopharmaceuticals is a publicly traded company on NCM using the ticker symbol KERX.
Detailed information on company financials and operating reports can be found here:
NCM: KERX
Keryx Biopharmaceuticals Annual Revenue and Growth Rate
Note: Keryx Biopharmaceuticals's revenues are gauged from an analysis of company filings.
Trademark Applications
Trademark applications show the products and services that Keryx Biopharmaceuticals is developing and marketing.
Keryx Biopharmaceuticals doesn't have any recent trademark applications, indicating Keryx Biopharmaceuticals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
FEXERIC Prescription pharmaceutical and medicinal preparations for the treatment and prevention of kidney diseases and disorders
07/24/2019
KERYX BIOPHARMACEUTICALS, INC Prescription pharmaceutical and medicinal preparations for the treatment and prevention of kidney diseases and disorders, administered in any way other than topically
03/19/2015
KINSCREEN Research and development services in the pharmaceutical and biopharmaceutical fields; services of computer modeling of compounds for use in the pharmaceutical and biopharmaceutical fields; licensing of intellectual property.; Research and development services in the pharmaceutical and biopharmaceutical fields; services of computer modeling of compounds for use in the pharmaceutical and biopharmaceutical fields; licensing of intellectual property.
05/23/2002
See all trademarks and details in the Full Report.
Market Share of Keryx Biopharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Keryx Biopharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Keryx Biopharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Keryx Biopharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.